Meridian Bioscience Announces Preliminary Revenue Results for Fiscal 2021 Q3
13 Jul 2021 //
GLOBENEWSWIRE
Meridian Resubmits Application to FDA for EUA for Revogene
28 Jun 2021 //
GLOBENEWSWIRE
Caraway Therapeutics Establishes Collaboration with AbbVie
09 Jun 2021 //
BUSINESSWIRE
AbbVie nabs option for Caraway`s preclinical Parkinson`s programme
09 Jun 2021 //
FIERCEBIOTECH
FDgard® shows Excellent Safety And Tolerability Profile for Functional Dyspepsia
28 Oct 2019 //
PR NEWS WIRE